• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 21, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Gut bacteria improve type 2 diabetes risk prediction

Bioengineer by Bioengineer
July 6, 2020
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Large-scale study with more than 4000 participants at ZIEL – Institute for Food & Health

IMAGE

Credit: A. Heddergott / TUM

The microbial composition of the intestines is complex and varies widely from one individual to another. Many factors such as environmental factors, lifestyle, genetics or illnesses affect the intestinal ecosystem of helpful gut bacteria.

Dirk Haller, Professor for Nutrition and Immunology at TUM, and his team have examined the importance of daytime-dependent fluctuations of the gut microbiome in relation to type 2 diabetes; they present their study encompassing more than 4000 people and it is the first study in this field based on a large prospective human cohort.

The relationship between gut bacteria and medical conditions

“In order to see whether changes in the gut microbiome allow conclusions about medical conditions, so-called prospective cohort studies are required,” explained Prof. Haller.

In these prospective cohort studies, a cross section of the population is being observed; however, none of the participants showed any signs of disease. This population is being re-examined over time. This way, researchers can find out whether a certain observation may be typical for future occurrences of diseases.

Diagnosis and outlook of type 2 diabetes may be improved

“When certain gut bacteria do not follow a day-night rhythm, so if their number and function does not change over the course of the day, this can be an indicator for a potential type 2 diabetes disease. Knowing this can improve diagnosis and outlook of type 2 diabetes,” said Chronobiologist Dr. Silke Kiessling, another contributor to the study.

These arrhythmic bacteria – those that are not changing between day and night – are a marker for potential disease. Researchers refer to this as a risk signature. “Mathematical models also show that this microbial risk signature consisting of arrhythmic bacteria helps diagnosing diabetes,” explained Sandra Reitmeier, first author on the study.

Primarily, the scientists analyzed data from an existing independent cohort by Helmholtz Zentrum München. The diabetes-related results were validated using additional cohorts from Germany. “By comparing our data to cohorts in England, we could confirm that there is – among other things – a strong regional factor affecting the microbial ecosystem. Therefore, there is a demand for finding locally specified arrhythmic risk signatures,” elaborated Haller.

Nutritionist Haller emphasizes that “apart from bacteria and their variations over the course of the day, other parameters such as the body mass index play a role in being able to better predict a person’s future medical conditions.”

Intestinal bacteria’s day and night rhythm as starting point for further research

Registering the time of day when taking human fecal samples for research purposes can heavily influence disease diagnostics. “Documenting these timestamps is essential for improving risk markers,” Prof. Haller emphasizes.

This research substantiates the hypothesis that changes in the microbiome have an effect of nutrition-related diseases. How gut bacteria changing (or not changing) during the day affect other microbiome-associated diseases such as Crohn’s disease or intestinal cancer may be subject to further scientific examination.

The results of this study are of particular importance for further work in the Collaborative Research Center of “Microbiome Signatures” (https://www.sfb1371.tum.de/), as cohort studies offer valuable possibilities of comparing data of healthy and ill subjects, particularly in the context of clinical studies.

###

Media Contact
Dirk Haller
[email protected]

Original Source

https://www.tum.de/nc/en/about-tum/news/press-releases/details/36118/

Related Journal Article

http://dx.doi.org/10.1016/j.chom.2020.06.004

Tags: BiologyDiabetesDiagnosticsGastroenterologyImmunology/Allergies/AsthmaMedicine/HealthMicrobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

STN1 Drives Pancreatic Cancer Metastasis via ZEB1

STN1 Drives Pancreatic Cancer Metastasis via ZEB1

August 21, 2025
Anxiety, Anxiety Medications Linked to Parkinson’s Risk

Anxiety, Anxiety Medications Linked to Parkinson’s Risk

August 21, 2025

Combination Therapy Enhances Treatment Outcomes in Advanced Triple-Negative Breast Cancer

August 21, 2025

Ambient Documentation Technologies Alleviate Physician Burnout and Rekindle Joy in Medical Practice

August 21, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Forces Within Tissues Sculpt Developing Organs

STN1 Drives Pancreatic Cancer Metastasis via ZEB1

Anxiety, Anxiety Medications Linked to Parkinson’s Risk

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.